Talis Biomedical (TLIS) Competitors

Talis Biomedical (NASDAQ:TLIS) and Cue Health (NASDAQ:HLTH) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, community ranking, analyst recommendations, risk, profitability and earnings.

Is TLIS or HLTH more profitable?

Cue Health has a net margin of -526.48% compared to Talis Biomedical's net margin of -5,784.73%. Cue Health's return on equity of -67.82% beat Talis Biomedical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Talis Biomedical	-5,784.73%	-79.74%	-57.16%
Cue Health	-526.48%	-67.82%	-53.79%

Do insiders & institutionals have more ownership in TLIS or HLTH?

43.8% of Talis Biomedical shares are owned by institutional investors. Comparatively, 45.5% of Cue Health shares are owned by institutional investors. 46.0% of Talis Biomedical shares are owned by insiders. Comparatively, 12.5% of Cue Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Does the MarketBeat Community prefer TLIS or HLTH?

Talis Biomedical received 8 more outperform votes than Cue Health when rated by MarketBeat users. Likewise, 37.50% of users gave Talis Biomedical an outperform vote while only 7.14% of users gave Cue Health an outperform vote.

Company	Underperform	Outperform
Talis Biomedical	Outperform Votes 9 37.50%	Underperform Votes 15 62.50%
Cue Health	Outperform Votes 1 7.14%	Underperform Votes 13 92.86%

Which has better earnings and valuation, TLIS or HLTH?

Talis Biomedical has higher earnings, but lower revenue than Cue Health. Talis Biomedical is trading at a lower price-to-earnings ratio than Cue Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Talis Biomedical	$2.13M	1.47	-$62.01M	-$28.02	-0.06
Cue Health	$70.94M	0.10	-$373.46M	-$2.44	-0.02

Does the media favor TLIS or HLTH?

In the previous week, Talis Biomedical had 1 more articles in the media than Cue Health. MarketBeat recorded 1 mentions for Talis Biomedical and 0 mentions for Cue Health. Talis Biomedical's average media sentiment score of 0.00 equaled Cue Health'saverage media sentiment score.

Company	Overall Sentiment
Talis Biomedical	Neutral
Cue Health	Neutral

Do analysts rate TLIS or HLTH?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Talis Biomedical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Cue Health	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has more risk and volatility, TLIS or HLTH?

Talis Biomedical has a beta of 1.56, meaning that its stock price is 56% more volatile than the S&P 500. Comparatively, Cue Health has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500.

Summary

Talis Biomedical and Cue Health tied by winning 7 of the 14 factors compared between the two stocks.